As key components of INHAT, the levels of ANP32A (also termed as I1PP2A) and SET (also termed as I2PP2A) are selectively upregulated in the brain regions affected with neurofibrillary pathology in AD [7–10]. This evidence concerns the gene ANP32A and Alzheimer disease.